Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pazopanib in Refractory GIST
NCT01524848Phase 2Completed
- Sponsor
- Scandinavian Sarcoma Group
- Start
- Feb 2012
- Primary completion
- Jan 2015
- Modality
- Small Molecules
- Countries
- 5
01
Overview
A Phase 2 trial of pazopanib in gastrointestinal stromal tumor (GIST), sponsored by Scandinavian Sarcoma Group. Started Feb 2012; status: completed.
02
Drugs
pazopanib
03
Conditions
gastrointestinal stromal tumor (GIST)
Beyond the preview
Go deeper on NCT01524848.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01524848.